Author:
Majidzadeh-A Keivan,Khalaj Vahid,Fatemeh Davami,Mahdi Hemayatkar,Farzaneh Barkhordari,Ahmad Adeli,Mahboudi Fereidoun
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference42 articles.
1. Bergmann, S. R., Fox, K. A., Ter-Pogossian, M. M., Sobel, B. E., & Collen, D. (1983). Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science, 220(4602), 1181–1183.
2. Van de Werf, F., Bergmann, S. R., Fox, K. A., de Geest, H., Hoyng, C. F., Sobel, B. E., et al. (1984). Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation, 69(3), 605–610.
3. Van de Werf, F., Ludbrook, P. A., Bergmann, S. R., Tiefenbrunn, A. J., Fox, K. A., de Geest, H., et al. (1984). Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. The New England Journal of Medicine, 310(10), 609–613.
4. Goldhaber, S. Z. (2005). Pulmonary thromboembolism. In D. L. Kasper, E. Braunwald, A. S. Fauci, et al. (Eds.), Harrison's Principles of Internal Medicine (16th ed., pp. 1561–1565). New York: McGraw-Hill.
5. Clagett, G. P., Sobel, M., Jackson, M. R., Lip, G. Y., Tangelder, M., & Verhaeghe, R. (2004). Antithrombotic therapy in peripheral arterial occlusive disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 126(3 Suppl), 609S–626S.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献